Investing
CapEx
Regeneron Pharmaceuticals CapEx decreased by 7.3% to $230.60M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 0.6%, from $229.30M to $230.60M. Over 4 years (FY 2021 to FY 2025), CapEx shows an upward trend with a 13.0% CAGR.
Analysis
StatementCash Flow Statement
SectionInvesting
CategoryGrowth
SignalContext dependent
VolatilityModerate
First reportedQ1 2013
Last reportedQ1 2026
How to read this metric
An increase signals growth investment or infrastructure modernization; a decrease might suggest cost-cutting or a transition to an asset-light model.
Detailed definition
Funds used by a company to acquire, upgrade, and maintain physical assets such as property, plants, buildings, technolog...
Peer comparison
Hardware-focused tech firms typically have higher CapEx relative to revenue than pure software companies due to manufacturing and supply chain needs.
Metric ID:
capital_expendituresHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $148.50M | $133.20M | $154.90M | $141.80M | $153.60M | $142.50M | $152.20M | $178.20M | $113.00M | $176.00M | $251.40M | $133.90M | $180.50M | $241.90M | $199.60M | $229.30M | $219.00M | $201.40M | $248.70M | $230.60M |
| QoQ Change | — | -10.3% | +16.3% | -8.5% | +8.3% | -7.2% | +6.8% | +17.1% | -36.6% | +55.8% | +42.8% | -46.7% | +34.8% | +34.0% | -17.5% | +14.9% | -4.5% | -8.0% | +23.5% | -7.3% |
| YoY Change | — | — | — | — | +3.4% | +7.0% | -1.7% | +25.7% | -26.4% | +23.5% | +65.2% | -24.9% | +59.7% | +37.4% | -20.6% | +71.2% | +21.3% | -16.7% | +24.6% | +0.6% |
Range$113.00M – $251.40M
CAGR+9.7%
Avg YoY Growth+15.6%
Median YoY Growth+14.2%
CapEx at Other Companies
Frequently Asked Questions
- What is Regeneron Pharmaceuticals's capex?
- Regeneron Pharmaceuticals (REGN) reported capex of $230.60M in Q1 2026.
- How has Regeneron Pharmaceuticals's capex changed year-over-year?
- Regeneron Pharmaceuticals's capex increased by 0.6% year-over-year, from $229.30M to $230.60M.
- What is the long-term trend for Regeneron Pharmaceuticals's capex?
- Over 4 years (2021 to 2025), Regeneron Pharmaceuticals's capex has grown at a 13.0% compound annual growth rate (CAGR), from $551.90M to $898.40M.
- What does capex mean?
- The money spent on long-term physical assets like machinery, data centers, and office buildings.